FCH
RMD icon

Freestone Capital Holdings’s ResMed RMD Stock Holding History

Freestone Capital Holdings’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-1,276
Closed -$309K – 552
2022
Q1 		$309K Buy
+1,276
New +$309K 0.01% 462
2021
Q1 		– Sell
-324
Closed -$68.9K – 959
2020
Q4 		$68.9K Buy
324
+61
+23% +$12.2K ﹤0.01% 499
2020
Q3 		$45.1K Buy
+263
New +$48.6K ﹤0.01% 502

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
OCBV
Ownership Capital B.V. Amsterdam, Netherlands $178M AUM 4.75% 1-Year Est. Return

Freestone Capital Holdings's RMD Position: Q2 2022 in Review

Freestone Capital Holdings sold out of ResMed (RMD) in Q2 2022, closing a stake of 1,276 shares — an estimated $309K sold.

Freestone Capital Holdings first reported a position in RMD in Q3 2020 and held it in 3 quarters. The position peaked at $309K in Q1 2022. 676 funds tracked by Wall St. Rank hold RMD as of Q2 2022.

  • Freestone Capital Holdings reported no remaining ResMed position as of Q2 2022 after selling out during the quarter.
  • Freestone Capital Holdings sold 1,276 ResMed shares in Q2 2022, an estimated $309K.
  • Freestone Capital Holdings first reported a position in ResMed in Q3 2020 and held it in 3 quarters.
  • Freestone Capital Holdings's ResMed position peaked at $309K in Q1 2022.
  • 676 funds tracked by Wall St. Rank held ResMed as of Q2 2022.

Based on Freestone Capital Holdings's 13F filing for Q2 2022, filed 9 Aug 2022.